National and Kapodistrian University of Athens
Μελέτη της επίδρασης των πρωτεϊνών με αμυλοειδή χαρακτηριστικά στην παθογένεια και εξέλιξη των νευροεκφυλιστικών νόσων
Abstract
dc:descriptionα-Synuclein, α small neuronal protein enriched in synaptic terminals, is biochemically and genetically linked to Parkinson's disease. α-Synuclein is the main protein component of Lewy bodies and neurites, which are the major pathological hallmarks of Parkinson's disease and other synucleinopathies. Many studies suggest that the selective a-Synuclein accumulation in proteinaceous inclusions, emerge as a result of unfolded monomeric α-Synuclein conversion to dimers and progressively to stable fibrilar structures. A growing body of evidence highlights the causative role of a-Synuclein secretion and cell-to-cell transmission in disease pathogenesis and progression. However, the mechanism of a-Synuclein accumulation in fibrilar structures in vivo remains elusive. a-Synuclein is subjected to several post-translational modifications (PTMs), that affect the solubility and the oligomerization of the protein. Among these PTMs, a growing interest has been focused on the phosphorylation at residue S129. Nearly all α-Synuclein accumulated within Lewy bodies is phosphorylated on serine 129 (Ser-129), but the significance of phosphorylation in the biology and pathophysiology of the protein is still controversial. Although the phosphorylation state of α-Synuclein appears to influence its aggregation propensity and toxicity, it is still not known whether phosphorylation promotes or prevents the aggregation and toxicity of α-Synuclein.To clarify a role of Ser129 phosphorylation of α-Synuclein in pathology progression, we performed stereotaxic injections targeting the mouse striatum with three fibrilar α-Synuclein types: wt-fibrils, phosphorylated S129 fibrils and, phosphorylation incompetent, S129A fibrils. With all three different fibrilar types injected, we were able to detect cytoplasmic pathological accumulations of phosphorylated α-Synuclein in the SNpc dopaminergic neurons and in cortical layers, resembling Lewy-bodies. These pathological accumulations are formed by progressive recruitment of endogenous a-Synuclein in fibrilar, proteinase-K resistant inclusions. Host expression of soluble α-Synuclein is an absolute prerequisite for the de novo formation of these inclusions, because inoculation of all fibrilar types in α-Synuclein null animals resulted in no pathology.We show, that in wt mice intracerebral injections of phosphorylated fibrils induced a more widespread formation of pathological inclusions and triggered dopaminergic neuronal loss compared to the other two fibrilar types. In agreement with the dopaminergic neuronal loss, significant reductions in the striatal concentrations of dopamine and fine motor symptoms were evident in inoculated animals.Interestingly, exacerbated pathology upon in vivo administration of P-PFF was associated with an altered innate immune response, early post injection. This was reflected by a decreased recruitment of CD45highCD11b+ macrophages from the peripheral lymphoid compartment, along with a significant decreased release of the anti-inflammatory cytokine IL-10 in the striatum. Pro-inflammatory TNF-α levels were significantly increased, both early and later during the course of inclusion formation, in mice injected with phosphorylated fibrils. Importantly, we found that phosphorylated fibrils are more efficiently uptaken by primary cortical neurons and lead to increased seeding and accumulation of the endogenous α-Synuclein.Overall, our data highlight the importance of phosphorylation in α-Synuclein induced pathology. Our experiments suggest that S129 phosphorylation, adds “aggregation” capacity to the α-Synuclein assemblies and accelerates pathology progression.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karampetsou, Adamantia
- Καραμπέτσου, Αδαμαντία
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44236